ID   LALW-2
AC   CVCL_K244
DR   Wikidata; Q54901905
RX   PubMed=2720561;
RX   PubMed=6609263;
CC   Characteristics: Established from a xenograft.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
RX   PubMed=6609263; DOI=10.1093/jnci/72.5.1029;
RA   White, Les
RA   Meyer, Paul R.
RA   Benedict, William F.
RT   "Establishment and characterization of a human T-cell leukemia line
RT   (LALW-2) in nude mice.";
RL   J. Natl. Cancer Inst. 72:1029-1038(1984).
//
RX   PubMed=2720561; DOI=10.1002/1097-0142(19890601)63:11<2103::AID-CNCR2820631106>3.0.CO;2-N;
RA   White, Les
RA   Haber, Michelle
RA   Brian, Michael J.
RA   Norris, Murray D.
RA   Trickett, Annette
RA   Sosula, Leo
RA   Tiley, Campbell
RA   Stewart, Bernard W.
RT   "Therapy-induced drug resistance in a human leukemia line (LALW-2). A
RT   clinically relevant model.";
RL   Cancer 63:2103-2110(1989).
//